MedTrace Logo

Etomidate/Propofol Mixture or Propofol Monotherapy Use in Patients Undergoing General Anesthesia

NCT03855267 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2019-02-26

No results posted yet for this study

Summary

The purpose of this study was to investigate the effects of different proportions of etomidate/propofol mixture and propofol alone intravenous anesthesia on intraoperative and postoperative physiological indicators and complications, and to find out the optimal use ratio of E/P mixture.

Conditions

  • Etomidate is Mixed With Propofol

Interventions

DRUG

Propofol 20 MG/ML

Pump propofol to keep bispectral index within 40 # 60

DRUG

Propofol 20 mg/ml , etomidate 2 mg/ml

Propofol was mixed with etomidate in different proportions.keep bispectral index within 40 # 60.

Sponsors & Collaborators

  • Guolin Wang

    lead OTHER

Principal Investigators

  • Guolin Wang, MD.PHD · Tainjin Medical University General Hospita

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2019-10-31
Completion
2019-12-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03855267 on ClinicalTrials.gov